PT98198A - Processo para a preparacao de novos derivados do acido 9-purinil-fosfonico e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de novos derivados do acido 9-purinil-fosfonico e de composicoes farmaceuticas que os contem

Info

Publication number
PT98198A
PT98198A PT98198A PT9819891A PT98198A PT 98198 A PT98198 A PT 98198A PT 98198 A PT98198 A PT 98198A PT 9819891 A PT9819891 A PT 9819891A PT 98198 A PT98198 A PT 98198A
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
phosphonic acid
new derivatives
Prior art date
Application number
PT98198A
Other languages
English (en)
Other versions
PT98198B (pt
Inventor
Charles Danzin
Serge Halazy
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PT98198A publication Critical patent/PT98198A/pt
Publication of PT98198B publication Critical patent/PT98198B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT98198A 1990-07-04 1991-07-03 Processo para a preparacao de novos derivados do acido 9-purinil-fosfonico e de composicoes farmaceuticas que os contem PT98198B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90401940 1990-07-04

Publications (2)

Publication Number Publication Date
PT98198A true PT98198A (pt) 1992-04-30
PT98198B PT98198B (pt) 1998-12-31

Family

ID=8205733

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98198A PT98198B (pt) 1990-07-04 1991-07-03 Processo para a preparacao de novos derivados do acido 9-purinil-fosfonico e de composicoes farmaceuticas que os contem

Country Status (22)

Country Link
US (2) US5538978A (pt)
EP (1) EP0465297B1 (pt)
JP (1) JP3006919B2 (pt)
KR (1) KR100217807B1 (pt)
CN (1) CN1031713C (pt)
AT (1) ATE133678T1 (pt)
AU (1) AU643533B2 (pt)
CA (1) CA2045783C (pt)
DE (1) DE69116750T2 (pt)
DK (1) DK0465297T3 (pt)
ES (1) ES2085446T3 (pt)
FI (1) FI101793B1 (pt)
GR (1) GR3019793T3 (pt)
HU (1) HU208832B (pt)
IE (1) IE72096B1 (pt)
IL (1) IL98702A (pt)
MX (1) MX9203682A (pt)
NO (1) NO180541C (pt)
NZ (1) NZ238774A (pt)
PT (1) PT98198B (pt)
TW (1) TW199896B (pt)
ZA (1) ZA914978B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0465297T3 (da) * 1990-07-04 1996-02-19 Merrell Pharma Inc 9-Purinylphosphonsyre-derivater
EP0531597A1 (en) * 1991-09-12 1993-03-17 Merrell Dow Pharmaceuticals Inc. Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine
AU658698B2 (en) * 1991-12-06 1995-04-27 Aventis Pharmaceuticals Inc. Novel trans cyclopentanyl purine analogs useful as immunosuppressants
US5817661A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5723466A (en) * 1991-12-06 1998-03-03 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5817672A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5817660A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5798340A (en) * 1993-09-17 1998-08-25 Gilead Sciences, Inc. Nucleotide analogs
US5656745A (en) * 1993-09-17 1997-08-12 Gilead Sciences, Inc. Nucleotide analogs
CA2171868A1 (en) * 1993-09-17 1995-03-23 Petr Alexander Method for dosing therapeutic compounds
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
MY141789A (en) * 2001-01-19 2010-06-30 Lg Chem Investment Ltd Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
EP2336133A1 (en) 2001-10-30 2011-06-22 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
TWI332956B (en) 2002-04-26 2010-11-11 Gilead Sciences Inc Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
US7432261B2 (en) 2003-04-25 2008-10-07 Gilead Sciences, Inc. Anti-inflammatory phosphonate compounds
US7407965B2 (en) 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
US7452901B2 (en) 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
US7470724B2 (en) 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
WO2005002626A2 (en) 2003-04-25 2005-01-13 Gilead Sciences, Inc. Therapeutic phosphonate compounds
US7300924B2 (en) 2003-04-25 2007-11-27 Gilead Sciences, Inc. Anti-infective phosphonate analogs
ATE490788T1 (de) 2003-04-25 2010-12-15 Gilead Sciences Inc Antivirale phosphonate analoge
US7427636B2 (en) 2003-04-25 2008-09-23 Gilead Sciences, Inc. Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
MXPA05011296A (es) 2003-04-25 2006-01-24 Gilead Sciences Inc Conjugados de fosfonato inhibidores de la cinasa.
BRPI0414533A (pt) 2003-09-18 2006-11-07 Conforma Therapeutics Corp composto, composição farmacêutica, e, métodos para inibir um hsp90 e para tratar um indivìduo tendo um distúrbio mediado por hsp90
JP2007508843A (ja) 2003-10-24 2007-04-12 ギリアード サイエンシーズ， インコーポレイテッド 治療用化合物の同定のための方法および組成物
WO2005044279A1 (en) * 2003-10-24 2005-05-19 Gilead Sciences, Inc. Purine nucleoside phosphonate conjugates
WO2005044308A1 (en) 2003-10-24 2005-05-19 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
US20080287471A1 (en) 2003-12-22 2008-11-20 Maria Fardis 4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity
ES2720618T3 (es) 2004-07-27 2019-07-23 Gilead Sciences Inc Análogos de fosfonato de compuestos de inhibidores de VIH
EP1869027A4 (en) 2005-03-30 2010-06-23 Conforma Therapeutics Corp ALKYNYL-PYRROLOPYRIMIDINES AND CORRESPONDING ANALOGS AS HSP90 INHIBITORS
US8158108B2 (en) * 2006-06-28 2012-04-17 S.C. Johnson & Son, Inc. VOC-free compressed gas aerosol compositions
US8178078B2 (en) * 2008-06-13 2012-05-15 S.C. Johnson & Son, Inc. Compositions containing a solvated active agent suitable for dispensing as a compressed gas aerosol
UA103329C2 (ru) 2008-07-08 2013-10-10 Гилиад Сайенсиз, Инк. Соли соединений-ингибиторов вич
KR101692133B1 (ko) 2015-01-13 2017-01-02 연세대학교 원주산학협력단 폴리이미드 수용액을 이용한 폴리이미드 성형방법
CN105061504A (zh) * 2015-09-16 2015-11-18 湖南大学 P-炔基磷酸酯类化合物的制备方法
PL3661937T3 (pl) 2017-08-01 2021-12-20 Gilead Sciences, Inc. Formy krystaliczne ((s)-((((2r,5r)-5-(6-amino-9h-puryn-9-ylo)-4-fluoro-2,5-dihydrofuran-2-ylo)oksy)metylo)(fenoksy)fosforylo)-l-alaninianu etylu (gs-9131) do leczenia zakażeń wirusowych

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1288098C (en) * 1984-08-24 1991-08-27 Richard L. Tolman 4-(guanin-9-yl)butanals and their 3-oxa, 3-thia and 2-ene derivatives having antiviral and antitumor activity
US4988702A (en) * 1986-08-26 1991-01-29 Warner-Lambert Company Novel 9-deazaguanines
EP0328834A1 (en) * 1988-02-16 1989-08-23 Merrell Dow Pharmaceuticals Inc. Novel aspartate transcarbamylase inhibitors
EP0335770B1 (en) * 1988-04-01 1997-01-15 Merrell Pharmaceuticals Inc. Novel fluorophosphonate nucleotide derivatives
US4927830A (en) * 1988-04-08 1990-05-22 The Regents Of The University Of Michigan Acyclic pyrrolo[2,3-D]pyrimidine analogs as antiviral agents
ATE98249T1 (de) * 1988-04-19 1993-12-15 Merrell Dow Pharma Phosphonoalkylpurin-derivate.
EP0338168A1 (en) * 1988-04-19 1989-10-25 Merrell Dow Pharmaceuticals Inc. Phosphonoalkylpurine derivatives
JPH02124898A (ja) * 1988-04-28 1990-05-14 Nippon Kayaku Co Ltd プリン塩基を有する新規化合物、その用途及び中間体
JPH02124897A (ja) * 1988-07-28 1990-05-14 Nippon Kayaku Co Ltd エリスロフラノシルヌクレオシド誘導体の製造法及び新規誘導体
GB8827339D0 (en) * 1988-11-23 1988-12-29 Wellcome Found Antiviral compounds
EP0374096B1 (de) * 1988-12-14 1992-12-02 Ciba-Geigy Ag 2',3'-Dideoxypurinnucleosid/Purinnucleosid-Phosphorylase-Inhibitor Kombinationstherapie und Zusammensetzungen dafür
DK0465297T3 (da) * 1990-07-04 1996-02-19 Merrell Pharma Inc 9-Purinylphosphonsyre-derivater
EP0468119A1 (en) * 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Novel carbocyclic analogs of certain nucleosides
EP0477454A1 (en) * 1990-09-28 1992-04-01 Merrell Dow Pharmaceuticals Inc. Novel phosphonate derivatives of certain nucleosides

Also Published As

Publication number Publication date
HU912253D0 (en) 1991-12-30
AU7941491A (en) 1992-01-09
ATE133678T1 (de) 1996-02-15
AU643533B2 (en) 1993-11-18
US5538978A (en) 1996-07-23
KR100217807B1 (ko) 1999-10-01
IL98702A (en) 1997-02-18
CA2045783A1 (en) 1992-01-05
ZA914978B (en) 1992-04-29
HUT59151A (en) 1992-04-28
DE69116750T2 (de) 1996-11-14
HU208832B (en) 1994-01-28
KR920002622A (ko) 1992-02-28
NZ238774A (en) 1993-08-26
FI913236A (fi) 1992-01-05
IL98702A0 (en) 1992-07-15
DK0465297T3 (da) 1996-02-19
NO912606L (no) 1992-01-06
US5527803A (en) 1996-06-18
EP0465297A1 (en) 1992-01-08
IE72096B1 (en) 1997-03-12
PT98198B (pt) 1998-12-31
FI913236A0 (fi) 1991-07-03
EP0465297B1 (en) 1996-01-31
DE69116750D1 (de) 1996-03-14
JP3006919B2 (ja) 2000-02-07
NO912606D0 (no) 1991-07-03
FI101793B (fi) 1998-08-31
TW199896B (pt) 1993-02-11
NO180541C (no) 1997-05-07
MX9203682A (es) 1992-08-01
GR3019793T3 (en) 1996-07-31
IE912329A1 (en) 1992-01-15
CN1031713C (zh) 1996-05-01
CN1058021A (zh) 1992-01-22
ES2085446T3 (es) 1996-06-01
CA2045783C (en) 2001-09-18
JPH04253989A (ja) 1992-09-09
NO180541B (no) 1997-01-27
FI101793B1 (fi) 1998-08-31

Similar Documents

Publication Publication Date Title
PT98198A (pt) Processo para a preparacao de novos derivados do acido 9-purinil-fosfonico e de composicoes farmaceuticas que os contem
PT91231A (pt) Processo de preparacao de derivados substituidos purinona e de composicoes farmaceuticas que os contem
PT94041A (pt) Processo para a preparacao de analogos de nucleosidos, em particulares derivadosde fosfonometoximetiloxi-purina/pirimidina e derivados de 4'-fosfonometoxitetra-hidrofuranil-1'purina/pirimidina, com accao anti-viral e anti-tumoral e de composicoes farmaceuticas que os contem
KR950700298A (ko) 뉴클레오시드 치료제(Therapeutic Nucleosides)
HUP0103641A2 (hu) Vírusellenes purinszármazékok és ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
AR004087A1 (es) Derivado del acido fenilacetico, procedimientos y productos intermedios para su obtencion y las composiciones que los contienen
BR8906119A (pt) Processo para preparar uma composicao topica
TW341574B (en) METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings.
ES8707545A1 (es) Un metodo para preparar compuestos de 2-cloro-2'-desoxiadenosin-5'-fosfato.
PT88306A (pt) Processo para a preparacao de nucleosidos de 2', 3'-dideoxi-3'-fluoro-pirimidina e de composicoes farmaceuticas que os contem
ATE57703T1 (de) Verfahren zur herstellung von 2,6-substituierten 9-(1,3-dihydroxy-2-propoxymethyl)-purinen und einige derivate.
PT88948A (pt) Processo para a preparacao de derivados de 3'-fluoro-2',3'-didesoxi-nucleosidos e de composicoes farmaceuticas que os contem
PT87930A (pt) Processo para a preparacao de derivados de acido 3-desmetil-4-fluor-mevalonico e de composicoes farmaceuticas que os contem
ES554178A0 (es) Un procedimiento para la preparacion de derivados de acidos griseolicos.
PT88335A (pt) Processo para a preparacao de derivados do acido 1,4-dihidro-4-oxo-3-quinolinocarboxilico e de composicoes farmaceuticas que os contem
PT94078A (pt) Processo para a preparacao de derivados de acido butenoico e de composicoes farmaceuticas que os contem
PT83269B (pt) Processo para a preparacao de derivados do acido 3-desmetil-mevalonico, de composicoes farmaceuticas que os contem bem como de intermediarios
PT89301A (pt) Processo para a preparacao de composicoes aquosas que contem um derivado do acido piperridinil-ciclo-pentil-heptenoico
BR8502505A (pt) Processo para a preparacao de derivados do acido fenoxifenilpropionico substituidos,composicoes herbicidas,processos para combater ervas daninhas e para a preparacao de composicoes
PT96287A (pt) Processo para a preparacao de derivados do acido 2-formilbenzilfosfonico e de composicoes farmaceuticas que os contem
PT84556B (pt) Processo para a preparacao de novos derivados de acido butenoico e de composicoes farmaceuticas que os contem
JPS6426594A (en) Nucleotides and antitumor agent
PT81800B (pt) Processo para a preparacao de carboxialquildipeptideos substituidos com (benzotiadiazina, benzamido e benzenossulfonil) fenilo uteis como agentes anti-hipertensivos e de composicoes farmaceuticas que os contem
IT7920769A0 (it) Derivati dell'acido mercaptopropionamido-acetico, processo per la loro preparazione e composizioni terapeutiche che licontengono.
BR8500880A (pt) Processo para a preparacao de derivados do acido fenoxi-propionico substituidos,composicoes herbicidas e processos para combater ervas daninhas e para a preparacao de composicoes

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19911216

FG3A Patent granted, date of granting

Effective date: 19980928

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040331